Atropine in Laparoscopic Gynaecological Surgery

PHASE4UnknownINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

May 31, 2017

Study Completion Date

August 31, 2017

Conditions
Laparoscopic SurgeryGynecology
Interventions
DRUG

Atropine

IV atropine 0.1%, 10 ml

DRUG

Placebo

IV saline, 10 ml

DRUG

Sevoflurane

All patients will receive anaesthesia based on sevoflurane, titrated to a bis of 45-60

DRUG

sugammadex

Patients will receive sugamadex for neuromuscular reversion, if necessary

DRUG

Ketorolac

60 mg IV ketorolac will be administered at induction, and patients will receive 30mg/8h on the postoperative period

DRUG

Morphine PCA

Patients will receive a PCA of morphine with a program of 0 (continuous infusion), 1 mg bolus and 8 minutes lockout

DRUG

rocuronium

general anaesthesia will use rocuronium 0.6 mg/kg to facilitate intubation

DRUG

propofol

for anaesthesia induction, patients will receive 2-3 mg/kg iv propofol

Trial Locations (1)

Unknown

Clinica Santa Maria, Santiago

Sponsors
All Listed Sponsors
lead

Clinica Santa Maria

OTHER

NCT02769325 - Atropine in Laparoscopic Gynaecological Surgery | Biotech Hunter | Biotech Hunter